The impact of glucose-lowering therapy on cardiovascular outcomes-Reference-Cited by-同舟云学术

The impact of glucose-lowering therapy on cardiovascular outcomes

Published:2009-06 Issue:3 Volume:23 Page:401-411
ISSN:1521-690X
Container-title:Best Practice & Research Clinical Endocrinology & Metabolism
language:en
Short-container-title:Best Practice & Research Clinical Endocrinology & Metabolism

Author:

Standl Eberhard,Müller Martin,Schnell Oliver

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference42 articles.

1. Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)

2. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD);Ryden;Diab Stoffw Herz,2007

3. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes;Nathan;Diabetologia,2006

4. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes;Nathan;Diabetologia,2009

5. Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones;Nathan;Diabetologia,2008

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential health effects of tomato (lycopersicon esculentum) juice and hypoglycemic amelioration in the atherogenic indices between diabetic animal models;Food Science and Technology;2022

2. Expression of a novel dual-functional polypeptide and its pharmacological action research;Life Sciences;2021-02

3. Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial;Inflammopharmacology;2016-12-07

4. Construction of a Fusion Peptide 5rolGLP-HV and Analysis of its Therapeutic Effect on Type 2 Diabetes Mellitus and Thrombosis in Mice;Applied Biochemistry and Biotechnology;2016-01-16

5. Cardiovascular impact of drugs used in the treatment of diabetes;Therapeutic Advances in Chronic Disease;2014-08-11